{"DataElement":{"publicId":"7352216","version":"1","preferredName":"Tumor Mass Bladder Neoplasm Histologic Type","preferredDefinition":"The type of tissue in which a malignant neoplasm involving the bladder originated.","longName":"6796606v1.0:7351874v1.0","context":"OCCPR","contextVersion":"1","DataElementConcept":{"publicId":"6796606","version":"1","preferredName":"Tumor Mass Histologic Type","preferredDefinition":"A benign or malignant pathologic structure in any part of the body, resulting from a neoplastic accumulation of cells._Refers to the type of tissue in which a tumor originated.","longName":"4976411v1.0:2673286v1.0","context":"OCCPR","contextVersion":"1","ObjectClass":{"publicId":"4976411","version":"1","preferredName":"Tumor Mass","preferredDefinition":"A benign or malignant pathologic structure in any part of the body, resulting from a neoplastic accumulation of cells.","longName":"C98275","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Mass","conceptCode":"C98275","definition":"A benign or malignant pathologic structure in any part of the body, resulting from a neoplastic accumulation of cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1DC5FA96-6845-8A34-E050-BB89AD4344BC","latestVersionIndicator":"Yes","beginDate":"2015-08-20","endDate":null,"createdBy":"DAVISJ","dateCreated":"2015-08-20","modifiedBy":"ONEDATA","dateModified":"2015-08-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2673286","version":"1","preferredName":"Histologic Type","preferredDefinition":"Refers to the type of tissue in which a tumor originated.","longName":"C61478","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic Type","conceptCode":"C61478","definition":"Refers to the type of tissue in which a tumor originated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3820C878-7530-31CC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-20","endDate":null,"createdBy":"UMLLOADER_BCR","dateCreated":"2007-08-20","modifiedBy":"ONEDATA","dateModified":"2007-08-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"8C3F2573-4FAB-6BB5-E053-F662850AE327","latestVersionIndicator":"Yes","beginDate":"2019-06-26","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-06-26","modifiedBy":"KNABLEJ","dateModified":"2020-02-14","changeDescription":"2/14/20 jk Upd RD to \"Qualified\"; CPTAC released AI. 1/2/20 jk Released per CPTAC SME (Linda) for PRAD Baseline CRF. 7/26/19 jk Updated OC term to Tumor Mass; used on multiple CPTAC CRFs.  6/26/19 jk created for CPTAC Baseline CRFs.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7351874","version":"1","preferredName":"Bladder Neoplasm Histologic Type","preferredDefinition":"Cancer or tumors of the bladder._Refers to the type of tissue in which a tumor originated._Something distinguishable as an identifiable class based on common qualities.","longName":"7351874v1.0","context":"OCCPR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Low-Grade Papillary Urothelial Carcinoma","valueDescription":"Bladder Non-Invasive Papillary Urothelial Carcinoma, Low Grade","ValueMeaning":{"publicId":"7352210","version":"1","preferredName":"Bladder Non-Invasive Papillary Urothelial Carcinoma, Low Grade","longName":"7352210","preferredDefinition":"Bladder non-invasive papillary urothelial carcinoma characterized by minimal cytologic atypia and infrequent mitotic figures (usually limited to the lower half of the tumor). This type of carcinoma recurs frequently, may invade the bladder wall, and has a low risk of progression.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Non-Invasive Papillary Urothelial Carcinoma, Low Grade","conceptCode":"C27875","definition":"Bladder non-invasive papillary urothelial carcinoma characterized by minimal cytologic atypia and infrequent mitotic figures (usually limited to the lower half of the tumor). This type of carcinoma recurs frequently, may invade the bladder wall, and has a low risk of progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA6C9DBD-0C0D-5A75-E053-4EBD850A36A4","latestVersionIndicator":"Yes","beginDate":"2020-07-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-07-14","modifiedBy":"ONEDATA","dateModified":"2020-07-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AA6C9DBD-0C26-5A75-E053-4EBD850A36A4","beginDate":"2020-07-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-07-14","modifiedBy":"ONEDATA","dateModified":"2020-07-14","deletedIndicator":"No"},{"value":"Urothelial Carcinoma In Situ","valueDescription":"Carcinoma in situ: flat tumor","ValueMeaning":{"publicId":"3442959","version":"1","preferredName":"Carcinoma in situ: flat tumor","longName":"3442959","preferredDefinition":"A flat urothelial lesion of variable thickness in the bladder, devoid of papillary structures containing cytologically malignant cells. (WHO 2016)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Urothelial Carcinoma In Situ","conceptCode":"C37266","definition":"A flat urothelial lesion of variable thickness in the bladder, devoid of papillary structures containing cytologically malignant cells. (WHO 2016)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE8A053C-B5EE-0643-E040-BB89AD436B32","latestVersionIndicator":"Yes","beginDate":"2012-04-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-25","modifiedBy":"COOPERM","dateModified":"2020-03-16","changeDescription":"Added concept annotation and removed special characters for MDR data migration. 3.16.20 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AA6C9DBD-0BD9-5A75-E053-4EBD850A36A4","beginDate":"2020-07-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-07-14","modifiedBy":"ONEDATA","dateModified":"2020-07-14","deletedIndicator":"No"},{"value":"High-Grade Papillary Urothelial Carcinoma","valueDescription":"Bladder Non-Invasive Papillary Urothelial Carcinoma, High Grade","ValueMeaning":{"publicId":"7352208","version":"1","preferredName":"Bladder Non-Invasive Papillary Urothelial Carcinoma, High Grade","longName":"7352208","preferredDefinition":"Bladder non-invasive papillary urothelial carcinoma characterized by marked architectural and cytologic abnormalities and frequent mitotic figures (at all levels of the urothelium).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Non-Invasive Papillary Urothelial Carcinoma, High Grade","conceptCode":"C27876","definition":"Bladder non-invasive papillary urothelial carcinoma characterized by marked architectural and cytologic abnormalities and frequent mitotic figures (at all levels of the urothelium).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA6C9DBD-0BE7-5A75-E053-4EBD850A36A4","latestVersionIndicator":"Yes","beginDate":"2020-07-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-07-14","modifiedBy":"ONEDATA","dateModified":"2020-07-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AA6C9DBD-0C00-5A75-E053-4EBD850A36A4","beginDate":"2020-07-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-07-14","modifiedBy":"ONEDATA","dateModified":"2020-07-14","deletedIndicator":"No"},{"value":"Micropapillary Urothelial Carcinoma","valueDescription":"Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant","ValueMeaning":{"publicId":"7350596","version":"1","preferredName":"Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant","longName":"7350596","preferredDefinition":"An infiltrating bladder transitional cell carcinoma exhibiting micropapillary growth pattern.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Bladder Micropapillary Urothelial Carcinoma","conceptCode":"C27202","definition":"An invasive bladder urothelial carcinoma exhibiting micropapillary growth pattern.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA09E87B-235C-6F92-E053-4EBD850A5BCD","latestVersionIndicator":"Yes","beginDate":"2020-07-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-07-09","modifiedBy":"ONEDATA","dateModified":"2020-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AA6C9DBD-0C3A-5A75-E053-4EBD850A36A4","beginDate":"2020-07-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-07-14","modifiedBy":"ONEDATA","dateModified":"2020-07-14","deletedIndicator":"No"},{"value":"Conventional Urothelial Carcinoma","valueDescription":"Urothelial Carcinoma","ValueMeaning":{"publicId":"3155848","version":"1","preferredName":"Urothelial Carcinoma","longName":"3155848","preferredDefinition":"A malignant neoplasm derived from the transitional epithelium of the urinary tract (urinary bladder, ureter, urethra, or renal pelvis).  It is frequently papillary. -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Urothelial Carcinoma","conceptCode":"C4030","definition":"A carcinoma arising from the urothelial lining of the urinary tract (bladder, renal pelvis, ureter, or urethra).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"943B8AF5-84AC-8068-E040-BB89AD437602","latestVersionIndicator":"Yes","beginDate":"2010-11-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-11-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AA6A1B59-683D-57B6-E053-4EBD850A8C85","beginDate":"2020-07-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-07-14","modifiedBy":"ONEDATA","dateModified":"2020-07-14","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other Histologic Type","ValueMeaning":{"publicId":"7331757","version":"1","preferredName":"Other Histologic Type","longName":"7331757","preferredDefinition":"A selected option that indicated an other histologic type.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other Histologic Type","conceptCode":"C159613","definition":"A selected option that indicated an other histologic type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A80C0DF2-F90A-58A8-E053-4EBD850A7EC2","latestVersionIndicator":"Yes","beginDate":"2020-06-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-14","modifiedBy":"ONEDATA","dateModified":"2020-06-14","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/03/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AA6A1B59-6848-57B6-E053-4EBD850A8C85","beginDate":"2020-06-07","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-07-14","modifiedBy":"ONEDATA","dateModified":"2020-07-14","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7351873","version":"1","preferredName":"Bladder Neoplasm Histologic Type Type","preferredDefinition":"Cancer or tumors of the bladder.:Refers to the type of tissue in which a tumor originated.:Something distinguishable as an identifiable class based on common qualities.","longName":"C2901:C61478:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Neoplasm","conceptCode":"C2901","definition":"A benign or malignant, primary or metastatic neoplasm of the bladder.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Histologic Type","conceptCode":"C61478","definition":"Refers to the type of tissue in which a tumor originated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA6A1B59-680A-57B6-E053-4EBD850A8C85","latestVersionIndicator":"Yes","beginDate":"2020-07-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-07-14","modifiedBy":"ONEDATA","dateModified":"2020-07-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA6A1B59-681B-57B6-E053-4EBD850A8C85","latestVersionIndicator":"Yes","beginDate":"2020-07-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-07-14","modifiedBy":"KNABLEJ","dateModified":"2020-07-31","changeDescription":"7/31/20 jk Released per SME (NGM) review and approval email. 7/14/20 jk created for CPTAC CESC baseline, local and path report CRFs.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"5635361","version":"1","longName":"Bladder","context":"OCCPR"},{"publicId":"6779606","version":"1","longName":"BLCA Baseline","context":"OCCPR"},{"publicId":"6779607","version":"1","longName":"BLCA Local Pathology","context":"OCCPR"},{"publicId":"6779608","version":"1","longName":"BLCA Pathology Review","context":"OCCPR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Histologic Type","type":"Preferred Question Text","description":"Histologic Type","url":null,"context":"OCCPR"}],"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"AA6C2FC3-03AE-5B75-E053-4EBD850A5A87","latestVersionIndicator":"Yes","beginDate":"2020-07-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-07-14","modifiedBy":"KNABLEJ","dateModified":"2020-07-31","changeDescription":"7/31/20 jk Released per SME (NGM) review and approval email.  7/22/20 jk added BLCA Path CSIs.  7/14/20 jk created for CPTAC BLCA baseline CRF.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}